Timothy Hatlen to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Timothy Hatlen has written about Randomized Controlled Trials as Topic.
Connection Strength
0.146
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study. Lancet Microbe. 2024 06; 5(6):e559-e569.
Score: 0.052
-
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. 2023 07 03; 6(7):e2323349.
Score: 0.049
-
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO). Med. 2022 08 12; 3(8):531-537.
Score: 0.046